NCT04384081View on ClinicalTrials.gov

A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

November 17, 2020

Study Completion Date

January 20, 2021

Conditions
Healthy
Interventions
DRUG

BI 456906

Solution for injection

DRUG

Placebo

Solution for injection

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04384081 - A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2 | Biotech Hunter | Biotech Hunter